Follow us:
© 2022 AventinHealty.com. All rights reserved.
Showing 19–27 of 52 results
-
MORE INFOGallant HF Cardiac Resynchronization Therapy Defibrillator (CRT-D)
Gallant™ HF CRT-D solutions use smartphone connectivity with extended therapy that you can intuitively program to make a powerful difference in the lives of your heart failure patients.
- Get fast, effective CRT optimization with SyncAV CRT technology
- Encourage greater patient engagement with app-based remote monitoring
- Provide powerful, lasting therapy with a small, contoured design with 1.5T and 3T MR Conditional*
-
MORE INFOHeartMate 2™
The HeartMate II™ LVAD is designed to provide short-term or long-term circulatory support for patients with advanced heart failure and is indicated in the United States for both target therapy and bridge to transplantation. Backed by over 10 years of data, the HeartMate II LVAD is the most widely used and most extensively studied LVAD in the world, implanted in more than 27,000 patients worldwide.
-
MORE INFOICM with Confirm Rx™ SharpSense Technology
Confirm Rx™ wearable cardiac monitor with SharpSense technology is designed to accurately detect arrhythmias so you can confidently diagnose bradycardia, pauses and atrial fibrillation. All Abbott ICMs also feature Bluetooth® wireless technology and an easy-to-use mobile app for reliable remote monitoring with fast and best-in-class patient engagement.
-
MORE INFOICM with Jot Dx™ SharpSense Technology
The Jot Dx™ ICM with SharpSense technology is the first ICM to allow you to switch between viewing three main sections and viewing all patient sections. Reduce your data load without sacrificing accuracy or review all data for hard-to-detect arrhythmias. All Abbott ICMs combine Bluetooth® wireless technology for fast and reliable remote monitoring and an easy-to-use mobile app for easier patient engagement.
-
MORE INFOIN.PACT™ Admiral™ | Paclitaxel and Drug Coated Balloon
The IN.PACT™ Admiral™ drug-coated balloon (DCB) is a clinically proven, primary endovascular therapy that treats femoropopliteal disease, reducing reinterventions and preserving future treatment options. IN.PACT Admiral DCB is indicated for de novo restenotic. or in-stent restenotic lesions up to 360 mm with a reference vessel diameter of 4 to 7 mm in the superficial femoral or popliteal arteries.
-
MORE INFOMerlin.net™ Patient Care Network (PCN)
Merlin.net™ Patient Care Network (PCN) is a web application for remote monitoring and management of patients with Abbott cardiac rhythm management (CRM) devices. The system allows you and other clinicians to monitor your patients’ heart conditions, monitor the performance of their devices, and manage delivery schedules.